about
Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survivalEmerging Role of miRNAs in the Drug Resistance of Gastric CancerDiagnostic Value of MicroRNAs for Urologic Cancers: A Systematic Review and Meta-AnalysisAdult Stem Cell Therapy for Stroke: Challenges and ProgressDysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin LymphomaCirculating MiR-125b as a marker predicting chemoresistance in breast cancerSerum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapyCirculating Plasma and Exosomal microRNAs as Indicators of Drug-Induced Organ Injury in Rodent ModelsCirculating miR-148b and miR-133a as biomarkers for breast cancer detection.Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers.MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.Circulating MicroRNA as Biomarkers: An Update in Prostate Cancer.Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling.Mechanisms and therapeutic potential of microRNAs in hypertension.MicroRNAs in diffuse large B-cell lymphoma.miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of GliomaPersonalized medicine in screening for malignant disease: a review of methods and applications.MicroRNAs as diagnostic biomarkers in gastric cancerRoles of microRNAs during prostatic tumorigenesis and tumor progression.MicroRNAs in body fluids as biomarkers for non-small cell lung cancer: a systematic review.Biosensor-based microRNA detection: techniques, design, performance, and challenges.Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.Pattern recognition for predictive, preventive, and personalized medicine in cancer.The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis.Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients.Piezoelectric Cantilever Biosensors for Label-free, Real-time Detection of DNA and RNA.Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse.Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.MicroRNAs in prostate cancer: From function to biomarker discovery
P2860
Q24294497-9B8FB521-0D32-4F28-9A06-7CA72322D3FDQ26752006-5F40706F-8509-4866-96A9-4E82F8A51C68Q26786185-E4FFDA57-7A36-49E2-B011-6C637344B387Q28066235-AB75B3C4-F1C3-4EA0-BC5E-67B4E47964A6Q28071905-9F357E52-BC81-4AF8-A814-F15C87E1DED2Q28482362-62FCA81E-C7D8-4D76-A68B-C3DAFE220D63Q33572407-D2769DB2-6757-497E-89FC-8045EDC859B5Q33878277-7B54B7E4-6876-484F-A1CC-7665F6F0E1FFQ34221705-7F0B685E-D036-4625-B0B8-93F1FB723E2EQ34768088-4A9B46B4-2782-4660-B768-5FF04E8A5148Q34846142-78643D49-3D02-4B85-8615-4B670BB5A66CQ35510445-3DD4378D-A699-4396-B03A-7F2476281A23Q35780870-91A5F018-47AD-4E15-823A-7371A2700748Q36151674-2E5B8AFF-8125-4871-ADD8-0F8FE8861C14Q36173562-56791EE6-72E1-4171-8354-3D92D6DF494CQ36524472-41B0D703-3B34-4534-B69A-CF08679FF31CQ36608190-6BF26FE0-AACE-47E5-8E80-5538D68C3975Q36641610-E3FA824F-7F38-470C-A5D9-BB9E18FAA287Q38064314-E434499E-D009-4454-A19C-908D814512C5Q38086009-6177E65B-7990-40F3-A207-CF8CC73B107BQ38143237-C61FD431-B6E0-401C-B347-834005F7FEF5Q38185669-0A1854F3-758C-4323-B40C-AF6AC8A7336BQ38435802-094B7A2C-0371-4A5A-97DE-D28E3FF993CEQ38670423-6FF9111E-01AA-4DA5-BBF4-C5ACFEECA4F3Q38748123-7DBBDC38-E2C7-4DC7-A020-47F945B045F1Q39529523-D89EFDCF-F7EB-4405-915A-D8E838407F2BQ45054702-C89586FC-47F3-4084-81F6-E47A4DA805C5Q54337409-E339409A-3EE3-4F1E-89CD-279A242DE8A2Q54918383-43DD3830-5BF4-4CDC-A2E3-B5C073DF203FQ55273685-CFB23FD2-8516-48CF-84D7-BC823A18817DQ55365141-4FCB2064-0C29-423E-8B51-7D11BE9A0E5CQ57112127-6B2FBE31-198D-4DC1-92E6-337E59FBBD2C
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Circulating microRNAs: potential biomarkers for cancer.
@ast
Circulating microRNAs: potential biomarkers for cancer.
@en
type
label
Circulating microRNAs: potential biomarkers for cancer.
@ast
Circulating microRNAs: potential biomarkers for cancer.
@en
prefLabel
Circulating microRNAs: potential biomarkers for cancer.
@ast
Circulating microRNAs: potential biomarkers for cancer.
@en
P2093
P2860
P921
P356
P1476
Circulating microRNAs: potential biomarkers for cancer.
@en
P2093
Qing-Guo Li
Xi-Wei Ding
Yi-Tao Ding
P2860
P304
P356
10.3390/IJMS12032055
P407
P5008
P577
2011-03-22T00:00:00Z